Literature DB >> 36119764

Incidence and outcomes of secondary infections in septic patients with cancer.

Shi-Ning Qu1, Hai-Jun Wang1, Chu-Lin Huang1, Hao Zhang1, Hao Wang1, Zhen-Nan Yuan1, Xue-Zhong Xing1.   

Abstract

Entities:  

Year:  2022        PMID： 36119764      PMCID： PMC9420672          DOI： 10.5847/wjem.j.1920-8642.2022.076

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN： 1920-8642


× No keyword cloud information.
  8 in total

1.  Immunosuppression and Secondary Infection in Sepsis: Part, Not All, of the Story.

Authors:  Derek C Angus; Steven Opal
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

Review 2.  The Immune System Regulation in Sepsis: From Innate to Adaptive.

Authors:  Yue Qiu; Guo-Wei Tu; Min-Jie Ju; Cheng Yang; Zhe Luo
Journal:  Curr Protein Pept Sci       Date:  2019       Impact factor: 3.272

3.  Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis.

Authors:  Dijoia B Darden; Scott C Brakenridge; Philip A Efron; Gabriela L Ghita; Brittany P Fenner; Lauren S Kelly; Alicia M Mohr; Lyle L Moldawer; Frederick A Moore
Journal:  Ann Surg       Date:  2021-10-01       Impact factor: 13.787

4.  Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.

Authors:  Lonneke A van Vught; Peter M C Klein Klouwenberg; Cristian Spitoni; Brendon P Scicluna; Maryse A Wiewel; Janneke Horn; Marcus J Schultz; Peter Nürnberg; Marc J M Bonten; Olaf L Cremer; Tom van der Poll
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

5.  Clinical characteristics, risk factors, immune status and prognosis of secondary infection of sepsis: a retrospective observational study.

Authors:  Yao Chen; Yanyan Hu; Jin Zhang; Yue Shen; Junling Huang; Jun Yin; Ping Wang; Ying Fan; Jianli Wang; Su Lu; Yilin Yang; Lei Yan; Keyong Li; Zhenju Song; Chaoyang Tong; Shilin Du
Journal:  BMC Anesthesiol       Date:  2019-10-18       Impact factor: 2.217

6.  Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.

Authors:  Anahita Rouzé; Ignacio Martin-Loeches; Pedro Povoa; Demosthenes Makris; Antonio Artigas; Mathilde Bouchereau; Fabien Lambiotte; Matthieu Metzelard; Pierre Cuchet; Claire Boulle Geronimi; Marie Labruyere; Fabienne Tamion; Martine Nyunga; Charles-Edouard Luyt; Julien Labreuche; Olivier Pouly; Justine Bardin; Anastasia Saade; Pierre Asfar; Jean-Luc Baudel; Alexandra Beurton; Denis Garot; Iliana Ioannidou; Louis Kreitmann; Jean-François Llitjos; Eleni Magira; Bruno Mégarbane; David Meguerditchian; Edgar Moglia; Armand Mekontso-Dessap; Jean Reignier; Matthieu Turpin; Alexandre Pierre; Gaetan Plantefeve; Christophe Vinsonneau; Pierre-Edouard Floch; Nicolas Weiss; Adrian Ceccato; Antoni Torres; Alain Duhamel; Saad Nseir
Journal:  Intensive Care Med       Date:  2021-01-03       Impact factor: 17.440

7.  Sustained reduction of healthcare-associated infections after the introduction of a bundle for prevention of ventilator-associated pneumonia in medical-surgical intensive care units.

Authors:  Carlos Magno Castelo Branco Fortaleza; Sebastião Pires Ferreira Filho; Marina de Oliveira Silva; Sandra Mara Queiroz; Ricardo de Souza Cavalcante
Journal:  Braz J Infect Dis       Date:  2020-09-16       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.